Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Quinic acid is a biologically active component of the Uncaria tomentosa extract C-Med 100(R).

Författare

  • Christina Silver
  • Hanna Lindgren
  • Ronald Pero
  • Tomas Leanderson
  • Fredrik Ivars

Summary, in English

We have previously reported that the C-Med 100® extract of the plant Uncaria tomentosa induces prolonged lymphocyte half life and hence increased spleen cell number in mice receiving the extract in their drinking water. Further, the extract induces cell proliferation arrest and inhibits activation of the transcriptional regulator nuclear factor κB (NF-κB) in vitro. We now report that mice exposed to quinic acid (QA), a component of this extract, had significantly increased number of spleen cells, thus recapitulating the in vivo biological effect of C-Med 100® exposure. Commercially supplied QA (H+ form) did not, however, inhibit cell proliferation in vitro, while the ammonia-treated QA (QAA) was a potent inhibitor. Both QA and QAA inhibited NF-κB activity in exposed cells at similar concentrations. Thus, our present data identify QA as a candidate component for both in vivo and in vitro biological effects of the C-Med 100® extract

Avdelning/ar

Publiceringsår

2005

Språk

Engelska

Sidor

219-229

Publikation/Tidskrift/Serie

International Immunopharmacology

Volym

5

Issue

1

Dokumenttyp

Artikel i tidskrift

Förlag

Elsevier

Ämne

  • Pharmacology and Toxicology

Nyckelord

  • Proliferation
  • Uncaria tomentosa
  • Inhibition
  • NF-κB
  • Cell survival

Status

Published

Forskningsgrupp

  • Diabetes - Immunovirology
  • Immunology

ISBN/ISSN/Övrigt

  • ISSN: 1878-1705